Over a lifetime horizon , CABG remained more costly than DES-PCI , but the incremental cost-effectiveness ratio was favorable ( $ 16 537 per quality-adjusted life-year gained ) and remained < $ 20 000 per quality-adjusted life-year in most bootstrap replicates .